1. Jennifer Hamilton, MS
PUBLICATIONS
Bennett JA, Hamilton J, Cadwallader AB, Kuennen R, Bidey P, Stadelmaier B, McCormick JR. Medium-Dependent
Phenotypes of Streptomyces coelicolor with Mutations in ftsI or ftsW. Journal of Bacteriology, Jan 2009, 191(2):661–4.
Cutler AJ, Kalali AH, Weiden PJ, Hamilton J, Wolfgang CD. Four-Week, Double-Blind, Placebo- and Ziprasidone-
Controlled Trial of Iloperidone in Patients with Acute Exacerbations of Schizophrenia. Journal of Clinical
Psychopharmacology, Apr 2008, 28(2 Suppl 1):S20-8.
STUDIES
Lavedan C, Licamele L, Volpi S, Hamilton J, Heaton C, Mack K, Lannan R, Thompson A, Wolfgang CD, Polymeropoulos
MH. Association of the NPAS3 Gene and Five Other Loci with Response to the Antipsychotic Iloperidone Identified in a
Whole Genome Association Study. Molecular Psychiatry Aug 2009, 14(8):804-19.
Volpi S, Heaton C, Mack K, Hamilton JB, Lannan R, Wolfgang CD, Licamele L, Polymeropoulos MH, Lavedan C. Whole-
Genome Association Study Identifies Polymorphisms Associated with QT Prolongation During Iloperidone Treatment of
Schizophrenia. Molecular Psychiatry Nov 2009, 14(11):1024-31.
PRESENTATIONS
Iloperidone Is Well Tolerated by Subjects with Renal or Hepatic Impairment in Single-Dose Clinical Pharmacokinetic
Studies (Institute for Psychiatric Services, New Orleans, LA, Oct 2007). Jennifer B. Hamilton, M.S., Greg Sedek, M.D.,
Curt D. Wolfgang, Ph.D.
Safety and Tolerability of Iloperidone in a Placebo- and Ziprasidone-Controlled Clinical Trial for Treatment of
Schizophrenia (161st
Annual Meeting of the American Psychiatric Association, Washington, DC, May 2008). Jennifer
Hamilton, M.S., Leslie Citrome, M.D., Curt D. Wolfgang, Ph.D., Paolo Baroldi, M.D.